drugset / Trial / NCT02629354

To Determine Blood Concentrations of Ibuprofen and Caffeine in a Tablet Against Ibuprofen Alone From Another Tablet

NCT02629354

Phase 1 Completed 36 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of the trial is to compare to combination of 400 mg ibuprofen and 100 mg caffeine against 400 mg ibuprofen alone under fed conditions

Timeline

Start
2015-11
Primary completion
2016-01
Completion
2016-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Caffeine Small molecule 100 mg
Comparator Ibuprofen Small molecule 400 mg

Indications

No indication recorded.